Mattioli Francesca, Martelli Antonietta, Garbero Claudia, Gosmar Marzia, Manfredi Valeria, Mattioli Francesco Paolo, Torre Giancarlo, Brambilla Giovanni
Division of Clinical Pharmacology and Toxicology, Department of Internal Medicine, University of Genoa, I-16132 Genoa, Italy.
Toxicol Appl Pharmacol. 2005 Mar 1;203(2):99-105. doi: 10.1016/j.taap.2004.07.009.
Four chemicals that are known to induce in rats thyroid follicular-cell adenomas and carcinomas were assayed for their ability to induce DNA damage and DNA repair synthesis in primary cultures of human thyroid cells. Significant dose-dependent increases in the frequency of DNA single-strand breaks and alkali-labile sites, as measures by the Comet assay, were obtained after a 20-h exposure to the following subtoxic concentrations of the four test compounds: 2,4-diaminoanisole (DAA) from 0.10 to 1.0 mM, 4,4'-methylene-bis(N,N-dimethyl)benzenamine (MDB) from 0.32 to 1.8 mM, propylthiouracil (PTU) from 1.8 to 5.6 mM, and 4,4'-thiodianiline (THA) from 0.032 to 0.18 mM. Under the same experimental conditions, DNA repair synthesis, as evaluated by quantitative autoradiography, was present in thyreocytes exposed to DAA but absent after treatment with MDB, PTU, and THA. Consistent with their thyroid-specific carcinogenic activity, all the four chemicals, administered p.o. in rats in a single dose corresponding to 1/2 LD50, induced a statistically significant degree of DNA fragmentation in the thyroid, whereas any substantial evidence of DNA lesions was absent in liver, kidney, and lung, which, with the exception of liver tumors caused by THA, are not targets of the carcinogenic activity of the four test compounds. These findings indicate that the DNA damage observed in thyroid cells was consistent with the carcinogenicity of the four test compounds, and suggest that DAA, MDB, PTU, and THA might be carcinogenic to thyroid in humans.
对已知能在大鼠中诱发甲状腺滤泡细胞腺瘤和癌的四种化学物质,检测了它们在人甲状腺细胞原代培养物中诱导DNA损伤和DNA修复合成的能力。通过彗星试验测定,在对四种受试化合物进行如下亚毒性浓度暴露20小时后,DNA单链断裂和碱不稳定位点的频率出现了显著的剂量依赖性增加:2,4 - 二氨基苯甲醚(DAA)浓度为0.10至1.0 mM,4,4'-亚甲基双(N,N - 二甲基)苯甲胺(MDB)浓度为0.32至1.8 mM,丙硫氧嘧啶(PTU)浓度为1.8至5.6 mM以及4,4'-硫代二苯胺(THA)浓度为0.032至0.18 mM。在相同实验条件下,通过定量放射自显影评估,暴露于DAA的甲状腺细胞中存在DNA修复合成,而在用MDB、PTU和THA处理后则不存在。与它们的甲状腺特异性致癌活性一致,所有这四种化学物质以相当于1/2 LD50的单剂量经口给予大鼠后,在甲状腺中诱导了具有统计学意义的DNA片段化程度,而在肝脏、肾脏和肺中未发现任何实质性的DNA损伤证据,除了THA引起的肝肿瘤外,这三种器官并非这四种受试化合物致癌活性的靶器官。这些发现表明,在甲状腺细胞中观察到的DNA损伤与四种受试化合物的致癌性一致,并提示DAA、MDB、PTU和THA可能对人类甲状腺具有致癌性。